|
|
| TABLE 2.7 Effects of Cannabinoids on the Immune System |
| Drug Tested | Type of Animal Experiment | Cell Types Tested or Concentration* | Drug Result | Reference |
| THC, 2-AG, 11-OH-THC, CBN | Lymphocytes and splenocytes in vitro | 0.130 µM | Higher doses suppressed T cell proliferation | Luo, 1992; Pross, 1992;b Klein, 1985;c Specter, 1990;d Lee, 1995;a Herring, 1998 |
| THC, 2-AG | Lymphocytes and splenocytes | 0.125 µM | Lower doses increased T cell proliferation in vitro | Luo, 1992; Lee, 1995;a Pross, 1992b |
| Anandamide | Splenocytes in vitro | 125 µM | Little or no effect on T cell proliferation | Lee, 1995;a Devane, 1992 |
| THC, 11-OH-THC, 2-AG | Splenocytes in vitro | 330 µM | Decreased B cell proliferation | Klein, 1985;c Lee, 1995a |
| THC, CP 55,940, WIN 55,212-2 | Lymphocytes in vitro | 0.1100 nM (0.00010.1 µM) | Increased B cell proliferation | Derocq, 1995 |
| THC | Drug injected into mice | >5 mg/kg | Antibody production suppressed | Baczynsky, 1983; Schatz, 1993 |
| HU-210 | Drug injected into mice | >0.05 mg/kg | Antibody production suppressed | Titishov, 1989 |
| THC, 11-OH-THC, CBD, CP 55,940, CBN | Splenocytes in vitro | 130 µM | Antibody production suppressed | Klein, 1990; Baczynsky, 1983; Kaminski, 1992, 1994; Herring, 1998 |
| THC | Drug injected into rodents | 3 mg/kg per day for 25 days, 40 mg/kg per day for 2 days | Repeated low doses or a high dose of THC suppressed the activity of natural killer cells | Patel, 1985; Klein, 1987 |
| THC, 11-OH-THC | Natural killer cells in vitro | 0.132 µM | Doses of >=10 µM suppressed natural killer cell cytolytic activity; doses <10 µM produced no effect | Klein, 1987; Luo, 1989 |
| THC | Peritoneal macrophages and monocytes | 330 µM | Variable doses of THC suppressed macophage functions in vitro | Lopez-Cepero, 1986; Specter, 1991; Tang, 1992 |
| THC, CBD | Drug injected into mice; in one case, in vitro tests done on spleens 4 days or 50 mg/kg every 5 days for up to 8 weeks | >5 mg/kg per day for | THC suppressed normal immune response; interferons failed to increase when exposed to cytokine inducer; CBD had no suppressive effect | Cabral, 1986; Blanchard, 1986 |
| THC, CBD | Peripheral blood mononuclear cells in vitro | <0.1 µM 30 µM | Increased interferon production Decreased interferon production | Watzl, 1991 |
| THC, CBD | Splenocytes and T cells in vitro | 10 µM | Both THC and CBD suppressed interleukin-2 secretion and number of interleukin-2 transcripts | Condie, 1996 |
| THC | Phorbol myristate acetate- differentiated macrophage in vitro | 1020 µM | Increased tumor necrosis factor production and interleukin-1 supernatant bioactivity | Shivers, 1994 |
| THC | Endotoxin-activated macrophages in vitro | 1030 µM | Increased processing and release of interleukin-1 rather than cellular production of interleukin-1 | Zhu, 1994 |
| THC | Peritoneal macrophages in vitro | 1030 µM | Increased interleukin-1 bioactivity | Klein, 1990 |
| THC | Drug and sublethal or lethal dose of Legionella pneumophilia injected in mice | 8 mg/kg before and after bacterial infection | Cytokine-mediated septic shock and death occurred with exposure to sublethal dose of bacteria | Klein, 1993, 1994; Newton, 1994 |
| <5 mg/kg doses or one 8 mg/kg or 4 mg/kg dose before bacteria infection | Survival occurred, but with greater susceptiblity to infection when challenged with bacteria and death when challenged with a lethal dose of bacteria | |||
| THC | Drug and herpes simplex virus injected in immunodeficient mice | 100 mg/kg before and after viral infection | Two high doses of THC potentiated the effects of herpes simplex and enhanced the progression of death | Specter, 1991 |
| 100 mg/kg before virual infection | Single dose did not promote death |
bMitogen dependent. cDependent on serum concentration in cell culture medium. dDependent on timing of drug exposure relative to mitogen exposure. *Drug concentrations are given in the standard format of molarity (M). A 1-M solution is the molecular weight of the compound (in grams) in 1 liter (L) of solution. The molecular weight of THC is 314, so a 1-M solution would be 314 g of THC in 1 L of solution, and a 10-µM solution would be 3.14 mg THC/L. A 1- to 10-µM concentration will generally elicit a physiologically relevant response in immune cell cultures. Higher doses are often suspected of not being biologically meaningful because they are much larger than would ever be achieved in the body. The doses listed in this table are, for the most part, very high. See text for further discussion. |